A meta-analysis of narrow band imaging for the diagnosis and therapeutic outcome of non-muscle invasive bladder cancer
To assess the additional detection rate (ADR) of within-patient comparisons of Narrow band imaging (NBI) and white light cystoscopy (WLC) for non-muscle invasive bladder cancer (NMIBC) detection and compare the impact of NBI and WLC on bladder cancer recurrence risk. We searched relevant studies fro...
Gespeichert in:
| Veröffentlicht in: | PloS one 2017-02, Vol.12 (2), p.e0170819-e0170819 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e0170819 |
|---|---|
| container_issue | 2 |
| container_start_page | e0170819 |
| container_title | PloS one |
| container_volume | 12 |
| creator | Xiong, YiQuan Li, JianDong Ma, ShuJuan Ge, Jing Zhou, LiZhi Li, Dongliang Chen, Qing |
| description | To assess the additional detection rate (ADR) of within-patient comparisons of Narrow band imaging (NBI) and white light cystoscopy (WLC) for non-muscle invasive bladder cancer (NMIBC) detection and compare the impact of NBI and WLC on bladder cancer recurrence risk.
We searched relevant studies from PubMed, Embase, Medline, Web of Science and the Cochrane Library database for all articles in English published beforeJuly26th, 2016. Pooled ADR, diagnostic accuracy, relative risk (RR) and their 95% confidence intervals (CIs) were calculated.
Twenty-five studies including 17 full texts and eight meeting abstracts were included for analysis. Compared to WLC, pooled ADR of NBI for NMIBC diagnosis was 9.9% (95% CI: 0.05-0.14) and 18.6% (95% CI: 0.15-0.25) in per-patient and per-lesion analysis, respectively. Pooled ADR of NBI for carcinoma in situ (CIS) diagnosis was 25.1% (95% CI: 0.09-0.42) and 31.1% (95% CI: 0.24-0.39) for per-patient and per-lesion analyses, respectively. The pooled sensitivity of NBI was significantly higher than WLC both at the per-patient (95.8% vs. 81.6%) and per-lesion levels (94.8% vs. 72.4%). In addition, NBI significantly reduced the recurrence rate of bladder cancer with a pooled RR value of 0.43 (95% CI: 0.23-0.79) and0.81 (95% CI: 0.69-0.95) at month three and twelve, respectively.
NBI is a valid technique that improves the diagnosis of NMIBC and CIS compared to standard WLC either at per-patient or per-lesion level. It can reduce the recurrence rate of bladder cancer accordingly. |
| doi_str_mv | 10.1371/journal.pone.0170819 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1867965879</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A481068825</galeid><doaj_id>oai_doaj_org_article_40dbae897240496ba403c6c7be83f47d</doaj_id><sourcerecordid>A481068825</sourcerecordid><originalsourceid>FETCH-LOGICAL-c791t-6bbd5e7056714e0339fd044108900cc60e4384bdf8310133d5b056b179cd83a73</originalsourceid><addsrcrecordid>eNqNk01r3DAQhk1padK0_6C0hkJpD7uVLFmSL4Ul9GMhEOjXVcjS2KtgS1vJ3jb_vnLWCbslh6CDxOiZVzOjmSx7idESE44_XPkxONUtt97BEmGOBK4eZae4IsWCFYg8PjifZM9ivEKoJIKxp9lJkdiCCnya7VZ5D4NaqCR1HW3MfZM7FYL_k9fKmdz2qrWuzRsf8mEDubGqdX4Cp9tkCWoL42B17sdB-x5uBLxb9GPUHeTW7VS0O8jrThkDIdfKaQjPsyeN6iK8mPez7OfnTz_Ovy4uLr-sz1cXC80rPCxYXZsSOCoZxxQQIVVjEKUYiQohrRkCSgStTSMIRpgQU9aJrTGvtBFEcXKWvd7rbjsf5VyyKLFgvGKl4FUi1nvCeHUltyElHK6lV1beGHxopQopvw4kRaZWICpeUEQrViuKiGaa1yBIQ7lJWh_n18a6B6PBDUF1R6LHN85uZOt3siSoRAwlgXezQPC_R4iD7G3U0HXKgR-nuHkhCC0FfgDKBKk4F2VC3_yH3l-ImWpVytW6xqcQ9SQqV6lVEBOimLSW91BpGeitTq3Y2GQ_cnh_5JCYAf4OrRpjlOvv3x7OXv46Zt8esBtQ3bCJvkut6F08Buke1MHHGKC5-w-M5DRJt9WQ0yTJeZKS26vDv7xzuh0d8g8egRgX</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1867965879</pqid></control><display><type>article</type><title>A meta-analysis of narrow band imaging for the diagnosis and therapeutic outcome of non-muscle invasive bladder cancer</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Public Library of Science (PLoS) Journals Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Xiong, YiQuan ; Li, JianDong ; Ma, ShuJuan ; Ge, Jing ; Zhou, LiZhi ; Li, Dongliang ; Chen, Qing</creator><contributor>Hurst, Robert</contributor><creatorcontrib>Xiong, YiQuan ; Li, JianDong ; Ma, ShuJuan ; Ge, Jing ; Zhou, LiZhi ; Li, Dongliang ; Chen, Qing ; Hurst, Robert</creatorcontrib><description>To assess the additional detection rate (ADR) of within-patient comparisons of Narrow band imaging (NBI) and white light cystoscopy (WLC) for non-muscle invasive bladder cancer (NMIBC) detection and compare the impact of NBI and WLC on bladder cancer recurrence risk.
We searched relevant studies from PubMed, Embase, Medline, Web of Science and the Cochrane Library database for all articles in English published beforeJuly26th, 2016. Pooled ADR, diagnostic accuracy, relative risk (RR) and their 95% confidence intervals (CIs) were calculated.
Twenty-five studies including 17 full texts and eight meeting abstracts were included for analysis. Compared to WLC, pooled ADR of NBI for NMIBC diagnosis was 9.9% (95% CI: 0.05-0.14) and 18.6% (95% CI: 0.15-0.25) in per-patient and per-lesion analysis, respectively. Pooled ADR of NBI for carcinoma in situ (CIS) diagnosis was 25.1% (95% CI: 0.09-0.42) and 31.1% (95% CI: 0.24-0.39) for per-patient and per-lesion analyses, respectively. The pooled sensitivity of NBI was significantly higher than WLC both at the per-patient (95.8% vs. 81.6%) and per-lesion levels (94.8% vs. 72.4%). In addition, NBI significantly reduced the recurrence rate of bladder cancer with a pooled RR value of 0.43 (95% CI: 0.23-0.79) and0.81 (95% CI: 0.69-0.95) at month three and twelve, respectively.
NBI is a valid technique that improves the diagnosis of NMIBC and CIS compared to standard WLC either at per-patient or per-lesion level. It can reduce the recurrence rate of bladder cancer accordingly.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0170819</identifier><identifier>PMID: 28192481</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Biology and Life Sciences ; Biopsy ; Bladder ; Bladder cancer ; Cancer ; Care and treatment ; Confidence intervals ; Cystoscopy ; Cystoscopy - methods ; Diagnosis ; Diagnostic systems ; Epidemiology ; Health risks ; Humans ; Image Enhancement - methods ; Invasiveness ; Laboratories ; Light ; Medical diagnosis ; Medical ethics ; Medicine ; Medicine and Health Sciences ; Meta-analysis ; Muscles ; Narrow band imaging ; Narrow Band Imaging - methods ; Neoplasm Invasiveness ; Patients ; Physical Sciences ; Public health ; Reproducibility of Results ; Research and Analysis Methods ; Sensitivity analysis ; Sensitivity and Specificity ; Studies ; Systematic review ; Tropical diseases ; Tumors ; Urinary bladder ; Urinary Bladder - diagnostic imaging ; Urinary Bladder - pathology ; Urinary Bladder Neoplasms - diagnosis ; Urinary Bladder Neoplasms - diagnostic imaging ; Urinary Bladder Neoplasms - therapy ; Urology ; White light</subject><ispartof>PloS one, 2017-02, Vol.12 (2), p.e0170819-e0170819</ispartof><rights>COPYRIGHT 2017 Public Library of Science</rights><rights>2017 Xiong et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2017 Xiong et al 2017 Xiong et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c791t-6bbd5e7056714e0339fd044108900cc60e4384bdf8310133d5b056b179cd83a73</citedby><cites>FETCH-LOGICAL-c791t-6bbd5e7056714e0339fd044108900cc60e4384bdf8310133d5b056b179cd83a73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5305060/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5305060/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,865,886,2103,2929,23871,27929,27930,53796,53798</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28192481$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Hurst, Robert</contributor><creatorcontrib>Xiong, YiQuan</creatorcontrib><creatorcontrib>Li, JianDong</creatorcontrib><creatorcontrib>Ma, ShuJuan</creatorcontrib><creatorcontrib>Ge, Jing</creatorcontrib><creatorcontrib>Zhou, LiZhi</creatorcontrib><creatorcontrib>Li, Dongliang</creatorcontrib><creatorcontrib>Chen, Qing</creatorcontrib><title>A meta-analysis of narrow band imaging for the diagnosis and therapeutic outcome of non-muscle invasive bladder cancer</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>To assess the additional detection rate (ADR) of within-patient comparisons of Narrow band imaging (NBI) and white light cystoscopy (WLC) for non-muscle invasive bladder cancer (NMIBC) detection and compare the impact of NBI and WLC on bladder cancer recurrence risk.
We searched relevant studies from PubMed, Embase, Medline, Web of Science and the Cochrane Library database for all articles in English published beforeJuly26th, 2016. Pooled ADR, diagnostic accuracy, relative risk (RR) and their 95% confidence intervals (CIs) were calculated.
Twenty-five studies including 17 full texts and eight meeting abstracts were included for analysis. Compared to WLC, pooled ADR of NBI for NMIBC diagnosis was 9.9% (95% CI: 0.05-0.14) and 18.6% (95% CI: 0.15-0.25) in per-patient and per-lesion analysis, respectively. Pooled ADR of NBI for carcinoma in situ (CIS) diagnosis was 25.1% (95% CI: 0.09-0.42) and 31.1% (95% CI: 0.24-0.39) for per-patient and per-lesion analyses, respectively. The pooled sensitivity of NBI was significantly higher than WLC both at the per-patient (95.8% vs. 81.6%) and per-lesion levels (94.8% vs. 72.4%). In addition, NBI significantly reduced the recurrence rate of bladder cancer with a pooled RR value of 0.43 (95% CI: 0.23-0.79) and0.81 (95% CI: 0.69-0.95) at month three and twelve, respectively.
NBI is a valid technique that improves the diagnosis of NMIBC and CIS compared to standard WLC either at per-patient or per-lesion level. It can reduce the recurrence rate of bladder cancer accordingly.</description><subject>Biology and Life Sciences</subject><subject>Biopsy</subject><subject>Bladder</subject><subject>Bladder cancer</subject><subject>Cancer</subject><subject>Care and treatment</subject><subject>Confidence intervals</subject><subject>Cystoscopy</subject><subject>Cystoscopy - methods</subject><subject>Diagnosis</subject><subject>Diagnostic systems</subject><subject>Epidemiology</subject><subject>Health risks</subject><subject>Humans</subject><subject>Image Enhancement - methods</subject><subject>Invasiveness</subject><subject>Laboratories</subject><subject>Light</subject><subject>Medical diagnosis</subject><subject>Medical ethics</subject><subject>Medicine</subject><subject>Medicine and Health Sciences</subject><subject>Meta-analysis</subject><subject>Muscles</subject><subject>Narrow band imaging</subject><subject>Narrow Band Imaging - methods</subject><subject>Neoplasm Invasiveness</subject><subject>Patients</subject><subject>Physical Sciences</subject><subject>Public health</subject><subject>Reproducibility of Results</subject><subject>Research and Analysis Methods</subject><subject>Sensitivity analysis</subject><subject>Sensitivity and Specificity</subject><subject>Studies</subject><subject>Systematic review</subject><subject>Tropical diseases</subject><subject>Tumors</subject><subject>Urinary bladder</subject><subject>Urinary Bladder - diagnostic imaging</subject><subject>Urinary Bladder - pathology</subject><subject>Urinary Bladder Neoplasms - diagnosis</subject><subject>Urinary Bladder Neoplasms - diagnostic imaging</subject><subject>Urinary Bladder Neoplasms - therapy</subject><subject>Urology</subject><subject>White light</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNk01r3DAQhk1padK0_6C0hkJpD7uVLFmSL4Ul9GMhEOjXVcjS2KtgS1vJ3jb_vnLWCbslh6CDxOiZVzOjmSx7idESE44_XPkxONUtt97BEmGOBK4eZae4IsWCFYg8PjifZM9ivEKoJIKxp9lJkdiCCnya7VZ5D4NaqCR1HW3MfZM7FYL_k9fKmdz2qrWuzRsf8mEDubGqdX4Cp9tkCWoL42B17sdB-x5uBLxb9GPUHeTW7VS0O8jrThkDIdfKaQjPsyeN6iK8mPez7OfnTz_Ovy4uLr-sz1cXC80rPCxYXZsSOCoZxxQQIVVjEKUYiQohrRkCSgStTSMIRpgQU9aJrTGvtBFEcXKWvd7rbjsf5VyyKLFgvGKl4FUi1nvCeHUltyElHK6lV1beGHxopQopvw4kRaZWICpeUEQrViuKiGaa1yBIQ7lJWh_n18a6B6PBDUF1R6LHN85uZOt3siSoRAwlgXezQPC_R4iD7G3U0HXKgR-nuHkhCC0FfgDKBKk4F2VC3_yH3l-ImWpVytW6xqcQ9SQqV6lVEBOimLSW91BpGeitTq3Y2GQ_cnh_5JCYAf4OrRpjlOvv3x7OXv46Zt8esBtQ3bCJvkut6F08Buke1MHHGKC5-w-M5DRJt9WQ0yTJeZKS26vDv7xzuh0d8g8egRgX</recordid><startdate>20170213</startdate><enddate>20170213</enddate><creator>Xiong, YiQuan</creator><creator>Li, JianDong</creator><creator>Ma, ShuJuan</creator><creator>Ge, Jing</creator><creator>Zhou, LiZhi</creator><creator>Li, Dongliang</creator><creator>Chen, Qing</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20170213</creationdate><title>A meta-analysis of narrow band imaging for the diagnosis and therapeutic outcome of non-muscle invasive bladder cancer</title><author>Xiong, YiQuan ; Li, JianDong ; Ma, ShuJuan ; Ge, Jing ; Zhou, LiZhi ; Li, Dongliang ; Chen, Qing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c791t-6bbd5e7056714e0339fd044108900cc60e4384bdf8310133d5b056b179cd83a73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Biology and Life Sciences</topic><topic>Biopsy</topic><topic>Bladder</topic><topic>Bladder cancer</topic><topic>Cancer</topic><topic>Care and treatment</topic><topic>Confidence intervals</topic><topic>Cystoscopy</topic><topic>Cystoscopy - methods</topic><topic>Diagnosis</topic><topic>Diagnostic systems</topic><topic>Epidemiology</topic><topic>Health risks</topic><topic>Humans</topic><topic>Image Enhancement - methods</topic><topic>Invasiveness</topic><topic>Laboratories</topic><topic>Light</topic><topic>Medical diagnosis</topic><topic>Medical ethics</topic><topic>Medicine</topic><topic>Medicine and Health Sciences</topic><topic>Meta-analysis</topic><topic>Muscles</topic><topic>Narrow band imaging</topic><topic>Narrow Band Imaging - methods</topic><topic>Neoplasm Invasiveness</topic><topic>Patients</topic><topic>Physical Sciences</topic><topic>Public health</topic><topic>Reproducibility of Results</topic><topic>Research and Analysis Methods</topic><topic>Sensitivity analysis</topic><topic>Sensitivity and Specificity</topic><topic>Studies</topic><topic>Systematic review</topic><topic>Tropical diseases</topic><topic>Tumors</topic><topic>Urinary bladder</topic><topic>Urinary Bladder - diagnostic imaging</topic><topic>Urinary Bladder - pathology</topic><topic>Urinary Bladder Neoplasms - diagnosis</topic><topic>Urinary Bladder Neoplasms - diagnostic imaging</topic><topic>Urinary Bladder Neoplasms - therapy</topic><topic>Urology</topic><topic>White light</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xiong, YiQuan</creatorcontrib><creatorcontrib>Li, JianDong</creatorcontrib><creatorcontrib>Ma, ShuJuan</creatorcontrib><creatorcontrib>Ge, Jing</creatorcontrib><creatorcontrib>Zhou, LiZhi</creatorcontrib><creatorcontrib>Li, Dongliang</creatorcontrib><creatorcontrib>Chen, Qing</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection (ProQuest)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xiong, YiQuan</au><au>Li, JianDong</au><au>Ma, ShuJuan</au><au>Ge, Jing</au><au>Zhou, LiZhi</au><au>Li, Dongliang</au><au>Chen, Qing</au><au>Hurst, Robert</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A meta-analysis of narrow band imaging for the diagnosis and therapeutic outcome of non-muscle invasive bladder cancer</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2017-02-13</date><risdate>2017</risdate><volume>12</volume><issue>2</issue><spage>e0170819</spage><epage>e0170819</epage><pages>e0170819-e0170819</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>To assess the additional detection rate (ADR) of within-patient comparisons of Narrow band imaging (NBI) and white light cystoscopy (WLC) for non-muscle invasive bladder cancer (NMIBC) detection and compare the impact of NBI and WLC on bladder cancer recurrence risk.
We searched relevant studies from PubMed, Embase, Medline, Web of Science and the Cochrane Library database for all articles in English published beforeJuly26th, 2016. Pooled ADR, diagnostic accuracy, relative risk (RR) and their 95% confidence intervals (CIs) were calculated.
Twenty-five studies including 17 full texts and eight meeting abstracts were included for analysis. Compared to WLC, pooled ADR of NBI for NMIBC diagnosis was 9.9% (95% CI: 0.05-0.14) and 18.6% (95% CI: 0.15-0.25) in per-patient and per-lesion analysis, respectively. Pooled ADR of NBI for carcinoma in situ (CIS) diagnosis was 25.1% (95% CI: 0.09-0.42) and 31.1% (95% CI: 0.24-0.39) for per-patient and per-lesion analyses, respectively. The pooled sensitivity of NBI was significantly higher than WLC both at the per-patient (95.8% vs. 81.6%) and per-lesion levels (94.8% vs. 72.4%). In addition, NBI significantly reduced the recurrence rate of bladder cancer with a pooled RR value of 0.43 (95% CI: 0.23-0.79) and0.81 (95% CI: 0.69-0.95) at month three and twelve, respectively.
NBI is a valid technique that improves the diagnosis of NMIBC and CIS compared to standard WLC either at per-patient or per-lesion level. It can reduce the recurrence rate of bladder cancer accordingly.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>28192481</pmid><doi>10.1371/journal.pone.0170819</doi><tpages>e0170819</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1932-6203 |
| ispartof | PloS one, 2017-02, Vol.12 (2), p.e0170819-e0170819 |
| issn | 1932-6203 1932-6203 |
| language | eng |
| recordid | cdi_plos_journals_1867965879 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; Public Library of Science (PLoS) Journals Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry |
| subjects | Biology and Life Sciences Biopsy Bladder Bladder cancer Cancer Care and treatment Confidence intervals Cystoscopy Cystoscopy - methods Diagnosis Diagnostic systems Epidemiology Health risks Humans Image Enhancement - methods Invasiveness Laboratories Light Medical diagnosis Medical ethics Medicine Medicine and Health Sciences Meta-analysis Muscles Narrow band imaging Narrow Band Imaging - methods Neoplasm Invasiveness Patients Physical Sciences Public health Reproducibility of Results Research and Analysis Methods Sensitivity analysis Sensitivity and Specificity Studies Systematic review Tropical diseases Tumors Urinary bladder Urinary Bladder - diagnostic imaging Urinary Bladder - pathology Urinary Bladder Neoplasms - diagnosis Urinary Bladder Neoplasms - diagnostic imaging Urinary Bladder Neoplasms - therapy Urology White light |
| title | A meta-analysis of narrow band imaging for the diagnosis and therapeutic outcome of non-muscle invasive bladder cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T11%3A35%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20meta-analysis%20of%20narrow%20band%20imaging%20for%20the%20diagnosis%20and%20therapeutic%20outcome%20of%20non-muscle%20invasive%20bladder%20cancer&rft.jtitle=PloS%20one&rft.au=Xiong,%20YiQuan&rft.date=2017-02-13&rft.volume=12&rft.issue=2&rft.spage=e0170819&rft.epage=e0170819&rft.pages=e0170819-e0170819&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0170819&rft_dat=%3Cgale_plos_%3EA481068825%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1867965879&rft_id=info:pmid/28192481&rft_galeid=A481068825&rft_doaj_id=oai_doaj_org_article_40dbae897240496ba403c6c7be83f47d&rfr_iscdi=true |